Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > A Lawrence Kenyon > Profile

A Lawrence Kenyon

Affiliations

  • Chief Financial Officer at Outlook Therapeutics Inc. (OTLK), 2024-03-22
  • Chief Financial Officer at Arno Therapeutics Inc (ARNI), 2014-02-27
  • President, Ceo And Cfo at Tamir Biotechnology Inc. (ACEL), 2012-07-25
  • Other at Par Pharmaceutical Companies Inc. (PRX), 2010-08-04
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
Outlook Therapeutics Inc.
 OTLK $1.83 10,000 Officer, Director 18,926 2021-04-20 Filing
Outlook Therapeutics Inc.
 OTLK $0.90 25,000 Officer, Director 82,213 2019-02-07 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
Outlook Therapeutics Inc.
 OTLK $1.70 1,350 Officer, Director 8,926 2019-09-18 Filing
Outlook Therapeutics Inc.
 OTLK $1.70 1,350 Officer, Director 80,863 2019-09-18 Filing
Oncobiologics Inc.
 ONS $0.87 10,100 Officer, Director 57,213 2018-09-18 Filing
Oncobiologics Inc.
 ONS $1.13 26,165 Officer 67,313 2017-12-22 Filing
Par Pharmaceutical Companies Inc.
 PRX $25.27 200 Officer 20,649 2010-03-03 Filing